Clinical Trial Update: Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial [Phase 1]

View source ↗

Summary

A single-center, randomized Phase 1 study evaluating the safety and feasibility of human umbilical cord mesenchymal stem cell-derived secretome for liver cirrho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Human umbilical cord mesenchymal stem cell-derived secretome

Snippet

Sponsor: Baermed | Conditions: Liver Cirrhosis | Phase 1 | Status: NOT_YET_RECRUITING